UMED (CEO Myungchan Park), a urology-focused healthcare startup, announced on October 28 that its automated bladder irrigation system UroRinse® Light has been certified as a medical device in Korea.  

UroRinse® Light is an automated system designed to address the inefficiencies and infection risks associated with manual bladder irrigation. It uses multiple sensors to automatically control the inflow and outflow of irrigation fluid and features a closed-loop design that minimizes external contamination and infection risks. By reducing the workload on healthcare providers and eliminating human error and procedural inconsistencies, the system delivers both reliable irrigation quality and improved clinical efficiency. Its compact size and intuitive user interface make it suitable not only for hospitals but also for long-term care facilities.

The safety and effectiveness of UroRinse® Light were demonstrated in a preclinical study published in June in Urology® (Gold Journal), showing superior performance compared to manual irrigation across all metrics, including efficiency, procedural consistency, and time savings. An editorial comment in the same issue highlighted the study as “a turning point toward the standardization of bladder irrigation to prevent catheter-related complications.”

With this certification, UMED plans to expand collaborations with major hospitals and long-term care facilities in Korea and strengthen its supply chain. Multiple medical institutions are already reviewing adoption, and the company aims to pursue FDA, CE, and other global regulatory approvals to accelerate international market entry.

CEO Myungchan Park (Professor of Urology, Haeundae Paik Hospital, Inje University) stated, “This certification is a significant milestone demonstrating that automation technology can meaningfully enhance patient safety and clinical efficiency. UMED will continue building a data-driven urologic health ecosystem that extends beyond treatment to include prevention and long-term management.”

UMED is a graduate of the IBK Changgong Busan 8th program and is supported by Series Ventures.